Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sailish Honap

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The New Zealand Medical Journal|April 13, 2023
Amoebic colitis masquerading as inflammatory bowel disease for a decadeSailish Honap, Simon Anderson
Alimentary Pharmacology & Therapeutics|August 21, 2023
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?Sailish Honap, Laurent Peyrin-Biroulet
Gastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|June 11, 2024
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized TrialsSailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Journal of Crohn'S & Colitis|October 30, 2024
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced TherapiesBénédicte Caron, Sailish Honap, Laurent Peyrin-Biroulet
European Journal of Gastroenterology & Hepatology|September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practiceSailish Honap, Peter M Irving, Mark A Samaan
Lancet (London, England)|August 12, 2023
Ulcerative colitisCatherine Le Berre, Sailish Honap, Laurent Peyrin-Biroulet
Nature Reviews. Drug Discovery|May 22, 2024
Navigating the complexities of drug development for inflammatory bowel diseaseSailish Honap, Vipul Jairath, Silvio Danese, et al.
Expert Opinion on Drug Safety|August 23, 2023
An update on the safety of long-term vedolizumab use in inflammatory bowel diseaseSailish Honap, Patrick Netter, Silvio Danese, et al.
Clinical and Experimental Gastroenterology|October 6, 2025
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel DiseaseMichael Colwill, Sailish Honap, Silvio Danese, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The New Zealand Medical Journal|April 13, 2023
Amoebic colitis masquerading as inflammatory bowel disease for a decadeSailish Honap, Simon Anderson
Alimentary Pharmacology & Therapeutics|August 21, 2023
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?Sailish Honap, Laurent Peyrin-Biroulet
Gastroenterology & Hepatology|February 26, 2024
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Sailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|June 11, 2024
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized TrialsSailish Honap, Silvio Danese, Laurent Peyrin-Biroulet
Journal of Crohn'S & Colitis|October 30, 2024
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced TherapiesBénédicte Caron, Sailish Honap, Laurent Peyrin-Biroulet
European Journal of Gastroenterology & Hepatology|September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practiceSailish Honap, Peter M Irving, Mark A Samaan
Lancet (London, England)|August 12, 2023
Ulcerative colitisCatherine Le Berre, Sailish Honap, Laurent Peyrin-Biroulet
Nature Reviews. Drug Discovery|May 22, 2024
Navigating the complexities of drug development for inflammatory bowel diseaseSailish Honap, Vipul Jairath, Silvio Danese, et al.
Expert Opinion on Drug Safety|August 23, 2023
An update on the safety of long-term vedolizumab use in inflammatory bowel diseaseSailish Honap, Patrick Netter, Silvio Danese, et al.
Clinical and Experimental Gastroenterology|October 6, 2025
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel DiseaseMichael Colwill, Sailish Honap, Silvio Danese, et al.
Pageof 6